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Background: High vegetable intake is associated with beneﬁcial eﬀects on bone. However, the mechanisms remain uncertain. Green leafy vegetables are a rich source of vitamin K1, which is known to have large eﬀects on
osteoblasts and osteocalcin (OC) metabolism.
Objective: To examine the eﬀects of consumption of two to three extra serves of green leafy vegetables daily on
bone metabolism.
Methods: Thirty individuals (mean age 61.8 ± 9.9 years, 67% male) completed three experimental phases in a
randomised controlled crossover design, each lasting four weeks, with a washout period of four weeks between
phases (clinical trial registration: ACTRN12615000194561). The three experimental phases were: (i) increased
dietary vitamin K1 by consuming green leafy vegetables (H-K; ~200 g/d containing 164.3 [99.5–384.7] μg/d of
vitamin K1); (ii) low vitamin K1 by consuming vitamin K1-poor vegetables (L-K; ~200 g/d containing 9.4
[7.7–11.6] μg/d of vitamin K1); and (iii) control (CON) where participants consumed an energy-matched nonvegetable control. OC forms, total OC (tOC), carboxylated OC (cOC) and undercarboxylated OC (ucOC), were
measured in serum pre- and post-intervention for each experimental phase using a sandwich-electrochemiluminescence immunoassay.
Results: Pre-intervention tOC, ucOC and ucOC:tOC levels were similar between phases (P > .05). Following HK, but not L-K, tOC, ucOC and ucOC:tOC levels were signiﬁcantly lower compared to pre-intervention levels
(P ≤ .001) and compared to CON (~14%, 31% and 19%, respectively, all P < .05), while cOC remained
unchanged.
Conclusions: In middle-aged healthy men and women, an easily achieved increase in dietary intake of vitamin

Abbreviations: BMD, bone mineral density; GCMS, gas-chromatography mass spectrometry; cOC, carboxylated osteocalcin; CON, control; CTX, collagen type I Cterminal cross-linked telopeptide; FFQ, food frequency questionnaire; H-K, experimental phase with high vitamin K1 intake; L-K, experimental phase with low
vitamin K1 intake; METs, metabolic equivalents; MK, menaquinones; PK, phylloquinone; P1NP, N-terminal propeptide of type I collagen; RCT, randomised controlled
trial; OC, osteocalcin; tOC, total osteocalcin; ucOC, undercarboxylated osteocalcin; ucOC:tOC, fraction of undercarboxylated osteocalcin; USDA, United States
Department of Agriculture; VIABP, Vegetable intake and blood pressure study; VKDP, vitamin K dependant proteins
⁎
Corresponding author at: School of Medical and Health Sciences, Edith Cowan University, Joondalup 6027, Western Australia, Australia.
E-mail address: marc.sim@ecu.edu.au (M. Sim).
1
Both authors contributed equally.
https://doi.org/10.1016/j.bonr.2020.100274
Received 15 April 2020; Accepted 21 April 2020
Available online 26 April 2020
2352-1872/ © 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/BY/4.0/).

Bone Reports 12 (2020) 100274

M. Sim, et al.

K1-rich green leafy vegetables substantially reduces serum tOC and ucOC suggesting increased entry of OC into
bone matrix, where it may improve the material property of bone. In conjunction with previous epidemiological
and randomised controlled trial data, these ﬁndings suggest that interventions to increase vegetable intake over
extended periods should include bone end points including fracture risk.

1. Introduction

weeks would result in lower blood pressure (Blekkenhorst et al., 2018).
In brief, the VIABP study was a randomised, open label controlled
crossover trial conducted at the Royal Perth Hospital Research Foundation, Perth, Australia. The study included one screening visit (to
determine eligibility) and three experimental phases, each lasting for
four weeks that were preceded by a 4-week washout period. The three
experimental phases included: (i) high dietary nitrate intake via consumption of green leafy vegetables; (ii) low dietary nitrate intake via
consumption of nitrate-poor vegetables; and (iii) no increase in vegetables (control; CON). As reported in the original investigation, despite
increases in plasma nitrate and nitrite after the green leafy vegetable
intervention, no eﬀects on blood pressure were recorded (Blekkenhorst
et al., 2018). Nevertheless, green leafy vegetables are also a rich source
of vitamin K1 (Gebhardt et al., 2008). The high and low nitrate phases
in the VIABP study were used in the current investigation to represent
high vitamin K1 (H-K) and low vitamin K1 (L-K) phases, respectively.
Throughout the 24-week trial period, participants were required to
limit their intake of green leafy vegetables, except whilst undertaking
the H-K intervention (formerly termed high nitrate). Computer generated random numbers were used to assign participants to one of six
sequence orders for the three experimental phases (Blekkenhorst et al.,
2018). The VIABP study was approved by the University of Western
Australia Human Research Ethics Committee and was carried out in
accordance with the Declaration of Helsinki. All participants provided
written consent.

Previous work, including our own, has identiﬁed observational
evidence for a reduction in fracture risk associated with increased vegetable intake (Blekkenhorst et al., 2017a; Benetou et al., 2016).
However, the potential role of phytochemical constituents underlying
such beneﬁt remains uncertain. Green leafy vegetables represent a rich
source of beneﬁcial bioactive components including nitrate
(Blekkenhorst et al., 2017b) and vitamin K1 (Bolton-Smith et al., 2000),
both of which may have beneﬁcial eﬀects on bone (Klein-Nulend et al.,
2014; Mott et al., 2019). Vitamin K is obtained from two principle
sources including vitamin K1 (phylloquinone: PK) found predominantly
in green leafy vegetables including their oils and vitamin K2 (menaquinones: MK) primarily synthesized by bacteria and found in foods
such as meat, dairy and fermented products (Walther et al., 2013a).
Vitamin K plays an important role in the γ-glutamyl carboxylation
of numerous vitamin K dependant proteins (VKDP) (Hauschka et al.,
1989). VKDP are best known for their role in blood coagulation as well
as in the inhibition of vascular calciﬁcation (e.g. matrix Gla protein)
(Hauschka et al., 1989; Szulc, 2016). Clinically, vitamin K antagonists
are used as anticoagulants in individuals with cardiovascular disease,
with oﬀ-target eﬀects on bone and blood vessel calciﬁcation reported
(Szulc, 2016; Binding et al., 2019). Vitamin K has also been implicated
in bone metabolism, with the non-collagenous VKDP, osteocalcin (OC)
synthesized exclusively in bone during its formation (Shea and Booth,
2016).
Osteocalcin is secreted by mature osteoblasts into the extracellular
matrix of bone and the general circulation (Gundberg et al., 2012).
Osteocalcin exists in the circulation in two major forms; carboxylated
OC (cOC) and undercarboxylated OC (ucOC). The cOC form is characterised by the presence of 3 gamma-carboxyl groups on glutamic acid
residues and is important for bone integrity due to its high aﬃnity for
hydroxyapatite (Gundberg et al., 1998). Alternatively, the ucOC form is
characterised by the presence of 0–2 gamma-carboxyglutamic acid residues (Hauschka et al., 1989). The ucOC fraction of total OC (tOC) in
serum has previously been shown to be inversely associated with vitamin K status (serum PK) (Booth et al., 2004; Rehder et al., 2015). As
such, the ucOC fraction is now being used as a biological indicator of
vitamin K suﬃciency (Booth, 2009). Current guidelines on vitamin K
reference values for Australia and New Zealand suggest adequate intakes of 70 and 60 μg/d for males and females respectively, for all ages
(National Health and Medical Research Council of Australia, 2006).
Slightly higher adequate intakes of 90 and 120 μg/d are recommended
for older males and females (≥51 years) in America (USDA. United
States Department of Health and Human Services, 2015). Whilst these
intakes may be adequate from the perspective of vitamin K-dependent
coagulation proteins (Binkley et al., 2002), the optimal vitamin K intake
for bone health remains unclear. Considering that higher vegetable
intake is universally promoted as part of a healthy diet, the aim of the
current study was to test whether extra consumption of green leafy
vegetables for four weeks would aﬀect surrogate markers of bone metabolism (OC forms) in healthy ambulant participants.

2.1. Participants
As detailed previously (Blekkenhorst et al., 2018), individuals with
pre-hypertension or untreated grade 1 hypertension were recruited
from the Perth general population. Sixty-ﬁve individuals were screened,
of which 32 were randomly assigned. Two participants withdrew after
randomisation due to medical reasons unrelated to the trial. Thirty
participants completed the study. All participants recruited were ambulant males and females aged between 40 and 74 years. These individuals had a resting mean ± SD systolic and diastolic blood pressure of 134 ± 8 and 78 ± 8 mmHg, respectively. Exclusion criteria
have previously been described in detail (Blekkenhorst et al., 2018).
Brieﬂy, participants were excluded if they: were a diabetic or a smoker,
had a body mass index ≥35 kg/m2 or < 18.5 kg/m2, or were taking
any of the following medications: antihypertensives, nitric oxide donors, organic nitrates and nitrites, or related drugs.
2.2. Screening visit
Prior to commencing the study, participants attended a screening
visit. Anthropometric measurements obtained at the screening visit
included height, weight, waist circumference, and hip circumference.
After blood tests conﬁrmed eligibility, participants were asked to return
to the research clinic to complete a medical examination by one of the
study physicians. Participants provided a list of current medications and
supplements, physical activity levels and a medical history. To calculate
physical activity levels, every 1 min of walking, moderate or vigorous
activity was multiplied by 3.5, 5.0 and 7.0 metabolic equivalents
(METs), respectively. Scores were subsequently summed to obtain total
METs/week (Australian Bureau of Statistics, 2013). During the
screening, participants completed a validated food frequency questionnaire (FFQ; Dietary Questionnaire for Epidemiological Studies
Version 2, DQES v2) (Ireland et al., 1994; Hodge et al., 2000; Giles and

2. Materials and methods
The data for the current study were collected as part of the
Vegetable
Intake
and
Blood
Pressure
(VIABP)
Study
(ACTRN12615000194561) to determine if daily consumption of nitrate-rich vegetables (which are also high in vitamin K1) over four
2
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2.3% and 4.8% at levels of 18 and 90 ng/mL, respectively. Serum ucOC
was determined using the same reagent assay with pre-intervention of
the serum samples using 5 mg/mL of hydroxyapatite (Calbiochem),
based on the method of Gundberg et al. (1983). The inter-assay imprecision for percentage binding of cOC was 8% and 12% at OC of 100
and 15 ng/mL, respectively.

Ireland, 1996) to obtain baseline dietary intake. A Registered Nutritionist supervised participants whilst completing the FFQ. Food models,
food charts, measuring cups and spoons were provided to ensure the
accuracy of reported food consumption.
2.3. Experimental phases: dietary intervention

2.6. Measurement of vitamin K1 in experimental beverages

Throughout each 4-week experimental phase, participants were
instructed to increase their vegetable intake by incorporating speciﬁc
vegetables blended into “juices” (the vegetables blended with water) or
a matching control beverage (energy matched using maltodextrin)
(Blekkenhorst et al., 2018). Participants were provided with a list of
vegetables that they could incorporate for the speciﬁc experimental
phases and were asked to maintain all meals as usual, with the exception of limiting vegetables that were high in nitrate typically also high
in vitamin K1. All intervention arms included the addition of onequarter of an orange ﬂesh for taste. In the H-K and L-K experimental
phases, participants consumed 100 g/d of vegetables, blended with
approximately 200 mL of water before breakfast and dinner meals,
equivalent to increasing vegetable intake by ~2.7 servings/d
(~200–300 kJ/d) (National Health and Medical Research Council of
Australian Dietary Guidelines, 2013). Participants were provided with
blenders and were asked to blend ≥3 diﬀerent vegetables of approximately equal weight. For the L-K intervention, participants were instructed that they could microwave, oven bake, boil, or steam any root
vegetables before consumption and were asked not to add any condiments (e.g., cooking oil, salt). For CON, participants blended 8 g maltodextrin with the one-quarter of an orange in water (approximately
energy matched to the vegetables consumed in the H-K and L-K intervention). To facilitate compliance and minimise potential loss-tofollow-up, participants consumed a sample juice for all three interventions and completed a juice acceptability questionnaire to ensure
willingness to participate prior to being randomly assigned. Participants kept a diary of the type and weight of all vegetables consumed in
all prepared juices for the H-K and L-K phases. Compliance was assessed
using intervention diaries and has been reported previously
(Blekkenhorst et al., 2018). Finally, participants were asked to freeze a
small sample of each intervention juice in a sterile 5-mL tube in the
week before their post-intervention visit. Vitamin K1 concentrations
were determined for intervention juices for a random sample of 15
participants during both H-K and L-K experimental phases.

Extraction procedures of vitamin K1 from juice was adapted from
the method by Gentili et al. (2014) and Schurgers and Vermeer (2000).
Brieﬂy, 0.2 g of juice was weighed into 15 mL screw-capped polyethylene centrifuge tubes then spiked with 5 ng of the K1-d7 internal
standard (Adrich cat # 705470). 1 mL of ethanol was added to denature
the proteins followed by, 2 mL of hexane and 1 mL of water for extraction. Samples were vortexed and shaken for 3 min, followed by
further mixing for 15 min in a ultrasound bath, 20 min on a gyratory
mixer, and underwent 30 s of sonication. Subsequently, samples were
centrifuged at 1800 ×g for 6 min at 4 °C, with 1 mL of the upper hexane
layer puriﬁed on silica columns (Agilent Bond Elut Si, 500 mg) which
were preconditioned with ether (4 mL) and hexane (4 mL), the samples
was applied and washed with hexane (4 mL) and the vitamin K1 eluted
with hexane:ether (96.5:3.5 v/v). The puriﬁed solution was collected
then dried under N2 at 25 °C, and dissolved in 100 μl dichloromethane
for analysis by gas-chromatography mass spectrometry (GCMS) using a
DB-1HT column in electron impact mode and selected ion monitoring.
The K1-d7 internal standard was monitored at m/e 457.7 and K1 at m/e
450.7.
2.7. Statistical analysis
Statistical signiﬁcance was accepted at a 2-sided type 1 error rate of
P < .05. All data were analysed by using IBM SPSS Statistics (IBM
Corp, Version 21.0. Armonk, NY) and STATA (Stata Statistical Software:
Release 15. College Station, TX: StataCorp LLC). Normality of distributions was tested with the use of the Shapiro-Wilk normality test.
Repeated measures ANOVA were used to examine if pre-treatment values for each OC form diﬀered between interventions, as well as the
absolute change (pre- to post-treatment) in OC forms between interventions. Post-treatment diﬀerences for each OC form between interventions (H-K, L-K and CON) were tested using linear mixed eﬀects
models with additional adjustments for pre-intervention levels.
Descriptive statistics of normally distributed continuous variables were
expressed as means ± SD, non-normally distributed continuous variables were expressed as medians and IQR, and categorical variables as
numbers and proportions (percentage).

2.4. Estimation of dietary vitamin K
At the screening visit, dietary intake for the previous 12 months was
assessed from the FFQ. Based on this information, total vitamin K intake
was calculated from all listed food and beverage items (n = 101) included on the FFQ, by multiplying the food item consumed (g/d) by the
mean vitamin K value (μg/g). Vitamin K1 (PK) values for FFQ food and
beverage items (n = 96) were obtained from the USDA National
Nutrient Database for Standard Reference (Release 28) (Gebhardt et al.,
2008). Vitamin K2 (MK-4 to MK-9) values (n = 43) for FFQ food and
beverage items were obtained from Schurgers and Vermeer (2000) and
MK-10 values (n = 6) for FFQ food items were obtained from Manoury
et al. (2013). Where foods and beverages containing vitamin K were not
available for FFQ items, a value of 0 μg/g was applied (PK n = 5; MK-4
to MK-9 n = 58; and MK-10 n = 95). For the vegetable juices consumed
in the experimental phases, vitamin K1 was calculated in a similar
manner using participant food diaries in-conjunction with the USDA
database (Gebhardt et al., 2008).

3. Results
Baseline clinical characteristics, demographics and dietary intake
for participants are presented in Table 1. Median [IQR] of total vitamin
K intake at the screening visit (assessed from the FFQ) was 136.7
[101.4–175.8] μg/d, with vitamin K1 from vegetables contributing 66.5
[41.1–93.5] μg/d. Based on participants' food diaries and the USDA
database (Gebhardt et al., 2008), the increase in vegetables in H-K, L-K
and CON was estimated to provide 324.2 [260.8–479.4] μg/d, 3.4
[3.3–3.7] μg/d and 0 μg/d, respectively, of vitamin K1. A list of vegetables consumed during H-K and L-K and their estimated vitamin K1
content are presented in Supplementary Table 1. The vitamin K1 levels
in H-K, L-K and CON juices, as analysed by GCMS, were 164.3
[99.5–384.7] μg/d, 9.4 [7.7–11.6] μg/d and 1.3 [0.8–2.9] μg/d, respectively.
Pre-treatment OC forms were not signiﬁcantly diﬀerent prior to
each of the three experimental phases (Table 2, P > .05). Post-intervention serum tOC, ucOC, cOC and ucOC:tOC levels for the three experimental phases are presented in Fig. 1. Post-treatment eﬀects were

2.5. Biochemistry
Serum tOC was measured by sandwich-electrochemiluminescence
immunoassay using the Roche Cobas N-Mid OC assay (Roche
Diagnostics, Mannheim). The inter-assay coeﬃcients of variation were
3
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variety of green leafy vegetables, in an amount that is easily achievable
(~200 g/d); thereby increasing the ease of applying such dietary
changes.
Regarding mechanism of action, previous work that supplemented
1000 μg/d of pharmaceutical PK for two weeks reported substantial
reduction in tOC and the fraction of ucOC, without eﬀects on other
markers of bone cell function including the osteoclast marker N-telopeptide of type I collagen or indeed another osteoblast marker bonespeciﬁc alkaline phosphatase (Binkley et al., 2000). The authors proposed that tOC may be the ﬁrst biochemical marker of bone turnover
aﬀected by PK supplementation, and other bone remodelling markers
could have been positively aﬀected with a longer follow-up. Noteworthy, in athletes with amenorrhea, PK supplementation resulted in
an unusual combination of increased bone formation markers with a
reduction bone resorption markers (Craciun et al., 1998). Contrarily, PK
supplementation (1 mg/d over 2 weeks) had no eﬀect on markers of
bone cell activity apart from OC in postmenopausal forearm fracture
patients (Douglas et al., 1995). Nonetheless, it may be that the eﬀect of
increased vitamin K on bone metabolism is to promote increased entry
of tOC into bone as identiﬁed by in vitro work (Atkins et al., 2009).
Speciﬁcally, observed eﬀects in H-K may be a result of increased γglutamyl carboxylation together with increased osteoblast-to-osteocyte
transition, while simultaneously decreasing the secretion of osteoclastogenic cytokines (Atkins et al., 2009). These results raise the possibility
of direct beneﬁcial eﬀects of improved OC binding to bone, which has
been associated with better material properties, particularly toughness
(Poundarik et al., 2012). Collectively, the aforementioned work may
help explain the positive inﬂuence that vitamin K has on bone formation and integrity.
Although the function of OC in bone is yet to be fully understood, in
epidemiological studies higher serum ucOC has been associated with
increased risk of hip fracture and reduced bone mineral density (Szulc
et al., 1996; Szulc et al., 1994). In older men, tOC has also been reported to be more predictive of hip fracture risk than other markers of
bone cell activity; including serum collagen type I C-terminal crosslinked telopeptide (CTX) and serum N-terminal propeptide of type I
collagen (P1NP) (Chubb et al., 2015). A separate investigation
(n = 1604, mean age 50 y) found that high serum fraction of ucOC was
associated with lower BMD at the hip (Booth et al., 2004). Noteworthy,
despite the aforementioned beneﬁts for bone, some evidence from animal models suggests that lower circulating levels of ucOC are associated with increased risk of cardiometabolic disease (Tacey et al.,
2018). However, an RCT in older women (n = 1368, aged ~75 y)
demonstrated that 1 year of calcium supplements lowered ucOC by
22%, with no eﬀect on glycated haemoglobin. These ﬁndings suggest
that animal models may not be applicable to humans (Lewis et al.,
2019). Given these conﬂicting ﬁnding, future work should explore how
changes in ucOC might inﬂuence other cardiometabolic outcomes.
Although most trials to date typically use large pharmaceutical
doses of vitamin K, an investigation reports older individuals (n = 888,
mean age 75 y) with the highest vitamin K intake (~250 μg/d) had a
65% lower relative risk for a hip fracture compared to those with the
lowest vitamin K intake (~60 μg/d) (Booth et al., 2000). An RCT performed in post-menopausal women (n = 181, age ~ 55 y), compared
three experimental arms of: (i) placebo, (ii) calcium, magnesium, zinc,
and vitamin D, or (iii) the same formulation with additional vitamin K1
(1 mg/day) for 3 years (Braam et al., 2003). The vitamin K1 supplemented group showed less bone loss at the femoral neck (1.7% 95%Cl
0.35–3.44) compared to the placebo group, while no diﬀerences were
observed at the lumbar spine. There was an 8% reduction in tOC recorded at 3 months and 12 months, while ucOC was 72% lower at
12 months. Of note, no diﬀerences in other bone turnover markers (e.g.
bone alkaline phosphatase (BAP), deoxypyridinoline) were observed.
Despite the much larger vitamin K1 dose, these long-term results are
comparable to our ﬁndings, where post-intervention tOC was 14% and
ucOC 31% lower in H-K compared to CON.

Table 1
Demographic, clinical characteristics and dietary intake of study participants at
the screening visita.
All participants (n = 30)
Demographics
Gender (male/ female)
Age (range)
BMI
Waist-to-hip ratiob
Previous smoker,b n (%)
Physical activity, METs/weekb,c
Clinical blood pressure
Systolic blood pressure, mm Hg
Diastolic blood pressure, mm Hg
Dietary intake
Total energy, g/d
Total vegetable, g/d
Total fruit, g/d
Carbohydrate, g/d
Protein, g/d
Fat, g/d
Alcohol, g/d
Vitamin K1, μg/d
Vitamin K2, μg/d
Total vitamin K, μg/d
a
b
c

20/10
63.0 (55.5–70.5)
27.0 ± 3.9
0.9 ± 0.1
11 (37.9)
1570 [720–2272]
133.6 ± 8.4
77.7 ± 8.0
8204.4 ± 2885.5
181.8 ± 75.8
256.1 [134.6–318.7]
202.8 ± 70.1
91.2 ± 34.7
80.6 ± 32.0
5.1 [0.8–17.0]
116.2 [77.0–147.7]
25.3 [20.5–33.8]
136.7 [101.4–175.8]

Values are means ± SDs, medians [IQRs] unless otherwise indicated.
n = 29.
Metabolic equivalents; METs.

Table 2
Mean ± SD pre-treatment levels of total osteocalcin (tOC), undercarboxylated
osteocalcin (ucOC), carboxylated osteocalcin (cOC) and the ratio of ucOC to
tOC in the control (CON), low-vitamin K1 (L-K) and high vitamin K1 (H-K)
phases.
Pre-treatment

tOC (μg/L)
ucOC (μg/L)
cOC (μg/L)
ucOC:tOC

P-value

CON

L-K

H-K

22.1 ± 6.3
8.2 ± 4.0
13.9 ± 5.2
0.37 ± 0.14

22.5 ± 7.3
8.0 ± 3.8
14.6 ± 6.2
0.36 ± 0.15

22.0 ± 6.4
8.1 ± 3.5
13.8 ± 5.5
0.38 ± 0.14

0.937
0.971
0.847
0.888

recorded between interventions for tOC, ucOC and ucOC:tOC (all
P ≤ .001) but not cOC (P = .246). When compared to L-K and CON,
participants receiving H-K had lower levels of tOC (22.4 and 22.8 vs.
19.5 μg/L, respectively; P ≤ .001, Fig. 1a), ucOC (8.1 and 8.8 vs.
6.0 μg/L, respectively; P < .001, Fig. 1b) and ucOC:tOC (0.37 and 0.38
vs. 0.31, respectively; P < .001, Fig. 1d). Absolute change (pre- to
post-intervention) in tOC, ucOC and ucOC:OC was signiﬁcantly greater
in H-K compared to L-K and CON (all P ≤ .01, Table 3).

4. Discussion
Our results demonstrate that short-term increases of ~200 g/d per
day of green leafy vegetable intake containing ~164 μg/d of vitamin K1
in H-K resulted in a 31% and 14% reduction in serum ucOC and tOC,
respectively, compared to CON. A previous dietary study of vitamin K1
supplementation through broccoli consumption at ~300 g/d (4 serves/
d), providing > 500% of the adequate intake of vitamin K, according to
USDA guidelines (National Health and Medical Research Council of
Australia, 2006), for 6 days identiﬁed reduced ucOC, but not tOC
(Booth et al., 1999). In the current investigation tOC levels were approximately two-fold higher at baseline than those of the previous study
and fell after HK. These diﬀerences in results may be attributable to
recent developments in assay technology, given normalisation equations were used previously. Another important distinction to the
aforementioned work is that the current intervention used a wide
4
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Fig. 1. Eﬀects of 4 weeks of control (CON), low vitamin K1 intake (L-K), and high vitamin K1 intake (H-K) vegetable juice on (a) total osteocalcin (tOC); (b)
undercarboxylated osteocalcin (ucOC); (c) carboxylated osteocalcin (cOC); and (d) the ratio of ucOC:tOC in serum. Post-intervention values are estimated
means ± SE, adjusted for pre-treatment values.

though the diet alone. Finally, the authors of both the aforementioned
meta-analysis also suggested that more work is required to substantiate
study conclusions.
Our data conﬁrms other work reporting that dietary vitamin K1
intakes of < 100 μg/d do not support the maximal carboxylation of OC
(Booth et al., 1999). Collectively, this suggests that existing adequate
intake reference levels of 70 and 60 μg/d for Australian men and
women may be too low (National Health and Medical Research Council
of Australia, 2006). There is currently no data on the average vitamin K
intake for Australian men and women. However, the average intake for
Americans from the 2011–2012 National Health and Nutrition Examination Survey was 138 and 122 μg/d for men and women, respectively (National Center for Health Statistics, Centers for Disease Control
and Prevention, 2013). Speciﬁcally, despite an estimated vitamin K
intake of 137 μg/g at the screening visit here, the additional 164 μg/d
of vitamin K1 as part of H-K further reduced ucOC. Vegetables are estimated to contribute between 50 and 80% of consumed vitamin K1
(Shearer and Newman, 2014; Nimptsch et al., 2008; Schurgers et al.,
1999), with the largest concentration found in green leafy vegetables
with concentrations of up to 400–700 μg/100 g (Shearer and Newman,
2014). Of importance, vegetables also contain a range of other macronutrients and micronutrients that are associated with better musculoskeletal health (Nicklett and Kadell, 2013). Considering only 7% of
Australian adults meet vegetable intake guidelines of 5–6 serves/d
(375–450 g/d) (National Health Survey, 2015), poor nutrition in
combination with insuﬃcient physical activity may contribute towards
the high prevalence of musculoskeletal-related diseases, such as osteoporosis (Wade et al., 2014). Collectively, this paper raises an important public health issue regarding optimal vitamin K1 intake and
should be considered as part of strategies when promoting increased
vegetable intake. Noteworthy, as intestinal bacteria are also involved in
synthesizing MKs (Beulens et al., 2013), more research is needed to

Table 3
Mean ± SD absolute change in pre- to post-intervention serum total osteocalcin (tOC), undercarobxylated osteocalcin (ucOC), carboxylated osteocalcin
(cOC) and the ratio of ucOC to tOC in the control (CON), low-vitamin K1 (L-K)
and high-vitamin K1 (H-K) vegetable juice interventions.
Absolute change
CON
tOC (μg/L)
ucOC (μg/L)
cOC (μg/L)
ucOC:tOC
⁎

0.69
0.62
0.07
0.01

±
±
±
±

1.84
1.16
1.71
0.04

L-K
−0.13 ± 2.23
0.15 ± 1.41
−0.29 ± 2.05
0.01 ± 0.07

H-K
−2.46
−2.07
−0.38
−0.07

±
±
±
±

3.44⁎
1.82⁎
2.75
0.53⁎

Signiﬁcantly diﬀerent to CON and L-K, P ≤ .01.

Similarly, in 381 postmenopausal women supplemented with PK
(1 mg/d), MK-4 (45 mg/d) or placebo for 12 months, despite PK and
MK-4 treatment reducing serum ucOC, other markers of bone metabolism including BAP and N-terminal telopeptide of type 1 collagen were
unaﬀected. Furthermore, no beneﬁts on lumbar spine or proximal
femur BMD or proximal femur geometric parameters were observed
(Binkley et al., 2009). Other work has also reported a lack of relationship between vitamin K status (e.g. serum PK) (Booth et al.,
2004), dietary vitamin K intake (Booth et al., 2000) and bone mineral
density. Nevertheless when considering hard outcomes, two recent
meta-analyses examining the eﬀect of vitamin K isoforms as a chemical
supplement (Mott et al., 2019) or as part of dietary intake (Hao et al.,
2017) report potential beneﬁcial links for fracture risk reduction. Speciﬁcally, vitamin K supplements were associated with 28% lower clinical fracture risk in post-menopausal and osteoporotic patients (Mott
et al., 2019). However, caution must be exercised when interpreting
these results as the vitamin K supplementation trials included a range of
pharmaceutical PK, MK-4 and/or MK-7 at dosages not attainable
5
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Sources of support

understand the role of the gut microbiome in contributing to overall
vitamin K status.
Strengths of this study relate to the randomised cross over study
design utilising two amounts of vegetable and the assessment of dietary
vitamin K using two separate methods. A power analysis also revealed
that this study was suﬃciently powered to detect meaningful diﬀerences in all outcomes. Regarding limitations of this paper, the bioavailability of vitamin K1 from foods can be reduced due to its poor bioaccessibility from the food matrix. For example, about 10% of vitamin
K1 is typically absorbed from cooked vegetables, with vitamin K1 absorption slightly increased by the presence of dietary lipids (Schurgers
and Vermeer, 2000). Secondly, as vitamin K content in foods vary by
region (Schurgers and Vermeer, 2000), the amount of vitamin K1 in
green leafy vegetables consumed in Perth, Western Australia, is likely to
diﬀer among other geographical locations. For example, the vitamin K1
content of the H-K juice estimated from the USDA database was ~50%
higher than that measured by directly by GCMS. Such ﬁndings are
consistent with previous work reporting large regional variations in the
vitamin K content of food (Walther et al., 2013b). As such, developing
region-speciﬁc vitamin K databases are an important consideration for
future epidemiological work assessing the relationship between vitamin
K intake and a range of health outcomes. Additional to vitamin K1,
green leafy vegetables are rich in nitrates that can positively inﬂuence
bone health (Klein-Nulend et al., 2014; Mott et al., 2019). Therefore,
any favourable eﬀects of green leafy vegetable intake for bone health
might be related to a combination of nutrients found in such vegetable
varieties. Furthermore, the inclusion of an additional control group
presenting with clinical vitamin K deﬁciency may have yielded different results. Finally, the inclusion of supplementary markers of bone
metabolism (e.g. CTX, P1NP, BAP) and structure (e.g. BMD, broadband
ultrasound attenuation of the heel bone) would have been ideal to attain more information regarding the relationship between green leafy
vegetables and bone health, especially in the context of a longer intervention (e.g. 1–2 years).
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